🚀 VC round data is live in beta, check it out!
Circio Holding Valuation Multiples
Discover revenue and EBITDA valuation multiples for Circio Holding and similar public comparables like Acumen Pharmaceuticals, Medeze Group, Searle Co., Precision BioSciences and more.
Circio Holding Overview
About Circio Holding
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.
Founded
2010
HQ
Employees
10
Website
Sectors
Financials (FY)
EV
$206M
Circio Holding Financials
Circio Holding reported last fiscal year revenue of — and negative EBITDA of ($5M).
In the same fiscal year, Circio Holding generated ($5M) in EBITDA losses and had net loss of ($5M).
Revenue (LTM)
Circio Holding P&L
In the most recent fiscal year, Circio Holding reported revenue of — and EBITDA of ($5M).
Circio Holding expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($5M) | XXX | XXX | XXX |
| Net Debt | — | — | $248K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Circio Holding Stock Performance
Circio Holding has current market cap of $206M, and enterprise value of $206M.
Market Cap Evolution
Circio Holding's stock price is $0.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $206M | $206M | -0.1% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCircio Holding Valuation Multiples
Circio Holding trades at (42.2x) EV/EBITDA.
EV / Revenue (LTM)
Circio Holding Financial Valuation Multiples
As of April 19, 2026, Circio Holding has market cap of $206M and EV of $206M.
Equity research analysts estimate Circio Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Circio Holding has a P/E ratio of (42.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $206M | XXX | $206M | XXX | XXX | XXX |
| EV (current) | $206M | XXX | $206M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (42.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (47.0x) | XXX | XXX | XXX |
| P/E | — | XXX | (42.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (42.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Circio Holding Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Circio Holding Margins & Growth Rates
Circio Holding's revenue in the last fiscal year declined by (100%).
Circio Holding's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Circio Holding Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (179%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Circio Holding Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Circio Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Acumen Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Medeze Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Searle Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Precision BioSciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Biomm | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Circio Holding M&A Activity
Circio Holding acquired XXX companies to date.
Last acquisition by Circio Holding was on XXXXXXXX, XXXXX. Circio Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Circio Holding
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCircio Holding Investment Activity
Circio Holding invested in XXX companies to date.
Circio Holding made its latest investment on XXXXXXXX, XXXXX. Circio Holding invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Circio Holding
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Circio Holding
| When was Circio Holding founded? | Circio Holding was founded in 2010. |
| Where is Circio Holding headquartered? | Circio Holding is headquartered in Norway. |
| How many employees does Circio Holding have? | As of today, Circio Holding has over 10 employees. |
| Is Circio Holding publicly listed? | Yes, Circio Holding is a public company listed on Oslo Børs. |
| What is the stock symbol of Circio Holding? | Circio Holding trades under CRNA ticker. |
| When did Circio Holding go public? | Circio Holding went public in 2016. |
| Who are competitors of Circio Holding? | Circio Holding main competitors are Acumen Pharmaceuticals, Medeze Group, Searle Co., Precision BioSciences. |
| What is the current market cap of Circio Holding? | Circio Holding's current market cap is $206M. |
| Is Circio Holding profitable? | No, Circio Holding is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.